AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

NCT02513563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: AZD1775

Sponsor

H. Lee Moffitt Cancer Center and Research Institute